• DOI:10.1007/s100720170012
• Corpus ID: 26091720

Pathological abnormalities in the normal-appearing white matter in multiple sclerosis

@article{Allen2001PathologicalAI,
  title={Pathological abnormalities in the normal-appearing white matter in multiple sclerosis},
  author={Ingrid V. Allen and Stephen McQuaid and Meenakshi Mirakhur and G. B. Nevin},
  journal={Neurological Sciences},
  year={2001},
  volume={22},
  pages={141-144}
}

• I. Allen, S. McQuaid, +1 author G. Nevin
• Published 1 April 2001
• Medicine, Biology
• Neurological Sciences

Abstract. In established cases of multiple sclerosis (MS), the normal-appearing white matter (NAWM), as defined for magnetic resonance imaging (MRI), is abnormal in the majority of cases. The clinical significance of these NAWM abnormalities is the subject of debate, but there is strong correlation with degree and progression of disability. New lesions form in NAWM before blood-brain barrier breakdown, as evidenced by gadolinium enhancement. The pathological basis of these neuroimaging abnormalities is largely unknown. Definitive pathological studies on the NAWM are few and are often based on small numbers of samples and of cases. Despite a variety of MS NAWM pathological studies, major research questions, of importance to our understanding of basic pathogenetic mechanisms and consequent rational therapies, remain unanswered. These relate to the frequency and extent of oligodendrocyte/myelin and axonal abnormalities in MS NAWM, and to the cellular basis of very early MS lesions detected by neuroimaging. In a pilot study of MS NAWM, microglial activation was demonstrated in 9 of 10 MS cases. We are currently testing the hypothesis that microglial activation, as defined by altered phenotype and HLA-DR positivity, will act as a marker for oligodendrocyte/myelin and axonal pathology in MS NAWM.